← back to search

Bum‐Kee Hong

Yonsei University · KR
Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Lipoproteins and Cardiovascular Health, and Cardiovascular Function and Risk Factors.
h-index
34
citations
9,721
works
253
NIH funding
primary concept
Medicine
email

Recent publications

Prognostic Implication of LDL-C Variability and Its Association with Lipid-Lowering Strategies: Insights from the RACING and LODESTAR Trials.
2025cited by 1position: contributordoi
P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent: The SHARE Randomized Clinical Trial.
2024cited by 18position: contributordoi
Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial.
2024cited by 1position: contributordoi
Determinants and effects of microvascular obstruction on serial change in left ventricular diastolic function after reperfused acute myocardial infarction.
2024cited by 0position: contributordoi
Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
2023cited by 64position: contributordoi
Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial.
2023cited by 39position: contributordoi
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial.
2023cited by 9position: contributordoi
Effect of moderate-intensity statin with ezetimibe combination vs. high-intensity statin therapy according to sex in patients with atherosclerosis.
2023cited by 6position: contributordoi
Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice.
2023cited by 4position: contributordoi
Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia.
2023cited by 4position: contributordoi
BioMatrix Versus Orsiro Stents for Coronary Artery Disease: A Multicenter, Randomized, Open-Label Study.
2023cited by 4position: contributordoi
Treat-to-target versus high-intensity statin treatment in patients with or without diabetes mellitus: a pre-specified analysis from the LODESTAR trial.
2023cited by 2position: contributordoi
Arterial Stiffness is Associated with False-Positive ST-Segment Depression in Supine Bicycle Exercise Stress Echocardiography.
2023cited by 0position: contributordoi
Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial.
2022cited by 231position: contributordoi
Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial.
2022cited by 21position: contributordoi
The association between cardiac involvement and long-term clinical outcomes in patients with Duchenne muscular dystrophy.
2022cited by 9position: contributordoi
Impact of aortic atheroma and distensibility on diastolic function and prognosis in patients with ischemic stroke.
2022cited by 1position: contributordoi
Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.
2021cited by 21position: contributordoi
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Patients With ST-Segment Elevation Myocardial Infarction.
2021cited by 20position: contributordoi
Coronary calcification is associated with elevated serum lipoprotein (a) levels in asymptomatic men over the age of 45 years: A cross-sectional study of the Korean national health checkup data.
2021cited by 18position: contributordoi
Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy.
2021cited by 13position: contributordoi
BioMatrix versus Orsiro biodegradable polymer stents in all-comer patients with coronary artery disease: the multicentre, randomised BIODEGRADE trial.
2021cited by 11position: contributordoi
Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO).
2021cited by 9position: contributordoi
Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and ≥60 years.
2021cited by 1position: contributordoi
Effect of Renal and Left Ventricular Function on Serial Pulmonary Arterial Pressure Changes after Device Closure of Atrial Septal Defect.
2021cited by 1position: contributordoi
Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial.
2020cited by 407position: contributordoi
Effect of Intravascular Ultrasound-Guided Drug-Eluting Stent Implantation: 5-Year Follow-Up of the IVUS-XPL Randomized Trial.
2020cited by 213position: contributordoi
Safety and Efficacy of a New Ultrathin Sirolimus-Eluting Stent with Abluminal Biodegradable Polymer in Real-World Practice.
2020cited by 13position: contributordoi
Differential contributions of sarcomere and mitochondria-related multigene variants to the endophenotype of hypertrophic cardiomyopathy.
2020cited by 11position: contributordoi
Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic-cardiomyopathy.
2020cited by 9position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Hyuck Moon Kwon · Hanseo University19 papers (2020–2024)Byoung Kwon Lee · SHARE16 papers (2019–2024)Eui‐Young Choi · Yonsei University15 papers (2019–2024)Jong-Youn Kim · Lodestar Research Corporation (United States)13 papers (2019–2024)Young-Guk Ko · Lodestar Research Corporation (United States)13 papers (2019–2025)Donghoon Choi · Research Institute of Industrial Science and Technology13 papers (2019–2025)Myeong-Ki Hong · Zhongshan Hospital of Xiamen University13 papers (2019–2025)Jung-Sun Kim · Bumin Hospital Group13 papers (2019–2025)Sung-Jin Hong · Keimyung University13 papers (2019–2025) · 11 papers (2019–2025)Seung‐Jun Lee · Boston University9 papers (2021–2025)Yangsoo Jang · CHA University Gangnam Medical Center7 papers (2019–2025) · 6 papers (2019–2021) · 4 papers (2020–2022)Sang‐Hyun Kim · Seoul National University College of Medicine3 papers (2019–2023)Junghan Yoon · Wonju Severance Christian Hospital3 papers (2020–2023)Pil-Ki Min · Yonsei University3 papers (2020–2021) · 3 papers (2020–2022) · 3 papers (2020–2021) · 3 papers (2020–2023)